LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,051,492 | +9.1% | 2,025,480 | +12.2% | 9.23% | -4.2% |
| Q2 2023 | $124,648,645 | +71.2% | 1,805,717 | +19.6% | 9.63% | +39.6% |
| Q1 2023 | $72,827,823 | +38.3% | 1,510,324 | +43.2% | 6.90% | +11.7% |
| Q4 2022 | $52,659,110 | +19.9% | 1,054,870 | -2.0% | 6.18% | +5.5% |
| Q3 2022 | $43,925,000 | -18.4% | 1,076,591 | +10.0% | 5.86% | -45.4% |
| Q2 2022 | $53,823,000 | +78.1% | 978,596 | +17.7% | 10.73% | +34.3% |
| Q1 2022 | $30,225,000 | +68.0% | 831,728 | +115.5% | 7.99% | +55.5% |
| Q4 2021 | $17,990,000 | – | 385,967 | – | 5.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |